Whole-exome sequencing identifies FANC heterozygous germline mutation as an adverse factor for immunosuppressive therapy in Chinese aplastic anemia patients aged 40 or younger: a single-center retrospective study.
Shen Y, Liu Q, Li H, Liu W, Hu H, Zhao Y, Li Y, Chen Y, Liu S, Yu Q, Zhuang H, Wu L, Hu Z, Zheng Z, Shen J, Lin S, Shen Y, Zhou Y, Ye B, Wu D.
Shen Y, et al. Among authors: liu s, liu q, liu w.
Ann Hematol. 2023 Mar;102(3):503-517. doi: 10.1007/s00277-023-05086-9. Epub 2023 Jan 9.
Ann Hematol. 2023.
PMID: 36622392
Free PMC article.